871
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Contrast-enhanced ultrasound-guided percutaneous microwave ablation of renal cell carcinoma that is inconspicuous on conventional ultrasound

, , , , , , & show all
Pages 607-613 | Received 21 Oct 2015, Accepted 24 Mar 2016, Published online: 07 Jun 2016

References

  • Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43–66.
  • Vander Eeckt K, Joniau S, Van Poppel H. Open surgery for localized RCC. Sci World J 2007;7:742–52.
  • Horn JC, Patel RS, Kim E, Nowakowski FS, Lookstein RA, Fischman AM. Percutaneous microwave ablation of renal tumors using a gas-cooled 2.4-GHz probe: Technique and initial results. J Vasc Intervent Radiol 2014;25:448–53.
  • Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Mu MJ, et al. Us-guided percutaneous microwave ablation of renal cell carcinoma: Intermediate-term results. Radiology 2012;263:900–8.
  • Liang P, Wang Y, Zhang DK, Yu XL, Gao YY, Ni XX. Ultrasound guided percutaneous microwave ablation for small renal cancer: Initial experience. J Urol 2008;180:844–8.
  • Moreland AJ, Ziemlewicz TJ, Best SL, Hinshaw JL, Lubner MG, Alexander ML, et al. High-powered microwave ablation of T1a renal cell carcinoma: Safety and initial clinical evaluation. J Endourol 2014;28:1046–52.
  • Piscaglia F, Nolsøe C, Dietrich CF, Cosgrove DO, Gilja OH, Bachmann Nielsen M, et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): Update 2011 on non-hepatic applications. Ultraschall Med 2012;33:33–59.
  • Spârchez Z, Radu P, Zaharia T, Kacso G, Grigorescu I, Badea R. Contrast enhanced ultrasound guidance: A new tool to improve accuracy in percutaneous biopsies. Med Ultrason 2010;12:133–8.
  • Yoon SH, Lee KH, Kim SY, Kim YH, Kim JH, Lee SH. Real-time contrast-enhanced ultrasound-guided biopsy of focal hepatic lesions not localised on B-mode ultrasound. Eur Radiol 2010;20:2047–56.
  • Di Vece F, Tombesi P, Ermili F, Sartori S. Contrast-enhanced ultrasound (CEUS) and CEUS-guided biopsy in the diagnosis of lung abscess in a patient with achalasia: Case report. Interv Med Appl Sci 2013;5:31–3.
  • Spârchez Z, Radu P, Kacso G, Eniu D, Hica S, Sparchez M. Contrast-enhanced ultrasound guided biopsy of superficial toraco-abdominal and neck lesions. Initial experience in 20 patients. Med Ultrason 2012;14:288–93.
  • Liu FY, Yu XL, Liang P, Cheng ZG, Han ZG, Dong BW. Contrast-enhanced ultrasound-guided microwave ablation for hepatocellular carcinoma inconspicuous on conventional ultrasound. Int J Hyperthermia 2011;27:555–62.
  • Carrafiello G, Mangini M, Fontana F, Recaldini C, Piacentino F, Pellegrino C, et al. Single-antenna microwave ablation under contrast-enhanced ultrasound guidance for treatment of small renal cell carcinoma: Preliminary experience. Cardiovasc Intervent Radiol 2010;33:367–74.
  • Zhao X, Wang W, Zhang S, Liu J, Zhang F, Ji C, Li X, et al. Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: A retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients. Abdom Imaging 2012;37:885–91.
  • Lackey L Jr, Peterson C, Barr RG. Contrast-enhanced ultrasound-guided radiofrequency ablation of renal tumors. Ultrasound Q 2012;28:269–74.
  • Kim AY, Lee MW, Rhim H, Cha DI, Choi D, Kim YS, et al. Pretreatment evaluation with contrast-enhanced ultrasonography for percutaneous radiofrequency ablation of hepatocellular carcinomas with poor conspicuity on conventional ultrasonography. Korean J Radiol 2013;14:754–63
  • Zhang M, Liang P, Cheng ZG, Yu XL, Han ZY, Yu J. Efficacy and safety of artificial ascites in assisting percutaneous microwave ablation of hepatic tumours adjacent to the gastrointestinal tract. Int J Hyperthermia 2014;30:134–41.
  • Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Zhang X, et al. US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: Intermediate-term results. Radiology 2014;270:880–7.
  • Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. Image-guided tumor ablation: Standardization of terminology and reporting criteria – a 10-year update. J Vasc Interv Radiol 2014;25:1691–705.
  • Park BK, Kim CK, Choi HY, Lee HM, Jeon SS, Seo SI, et al. Limitation for performing ultrasound-guided radiofrequency ablation of small renal masses. Eur J Radiol 2010;75:248–52.
  • Veltri A, Garetto I, Pagano E, Tosetti I, Sacchetto P, Fava C. Percutaneous RF thermal ablation of renal tumors: Is US guidance really less favorable than other imaging guidance techniques? Cardiovasc Intervent Radiol 2009;32:76–85.
  • Forman HP, Middleton WD, Melson GL, McClennan BL. Hyperechoic renal cell carcinomas: Increase in detection at US. Radiology 1993;188:431–4.
  • Yamashita Y1, Takahashi M, Watanabe O, Yoshimatsu S, Ueno S, Ishimaru S, et al. Small renal cell carcinoma: Pathologic and radiologic correlation. Radiology 1992;184:493–8.
  • Jamis-Dow CA, Choyke PL, Jennings SB, Linehan WM, Thakore KN, Walther MM. Small (≤3 cm) renal masses: Detection with CT versus US and pathologic correlation. Radiology 1996;198:785–8.
  • Tamai H, Takiguchi Y, Oka M, Shingaki N, Enomoto S, Shiraki T, et al. Contrast-enhanced ultrasonography in the diagnosis of solid renal tumors. J Ultrasound Med 2005;24:1635–40.
  • Meloni MF, Bertolotto M, Alberzoni C, Lazzaroni S, Filice C, Livraghi T, et al. Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: Contrast-enhanced sonography versus contrast-enhanced CT or MRI. Am J Roentgenol 2008;191:1233–8.
  • Lorentzen T, Skjoldbye BO, Nolsoe CP. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: Experience with 125 metastases in 39 patients. Ultraschall Med 2011;32:492–6.
  • Varkarakis IM, Allaf ME, Inagaki T, Bhayani SB, Chan DY, Su LM, et al. Percutaneous radio frequency ablation of renal masses: Results at a 2-year mean followup. J Urol 2005;174:456–60.
  • Arzola J, Baughman SM, Hernandez J, Bishoff JT. Computed tomography-guided, resistance-based, percutaneous radiofrequency ablation of renal malignancies under conscious sedation at two years of follow-up. Urology 2006;68:983–7.
  • Zagoria RJ, Hawkins AD, Clark PE, Hall MC, Matlaga BR, Dyer RB, et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: Factors influencing success. Am J Roentgenol 2004;183:201–7.
  • Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. Am J Roentgenol 2007;189:429–36.
  • Sommer CM, Lemm G, Hohenstein E, Bellemann N, Stampfl U, Goezen AS, et al. CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: Specific technical aspects and clinical results. Cardiovasc Intervent Radiol 2013;36:731–7.
  • Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Renal cell carcinoma: Clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003;226:417–24.
  • Wah TM, Irving HC, Gregory W, Cartledge J, Joyce AD, Selby PJ. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): Experience in 200 tumours. BJU Int 2014;113:416–28.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.